Stock Screener App

Frei -

Installieren

20.07

2.43% -0.50

Faeth Therapeutics Inc (FTH)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Faeth Therapeutics Inc Aktie (FTH) Neueste Nachrichten

Faeth Therapeutics, Inc.Common Stock (Nasdaq:FTH) Stock Quote - FinancialContent

Faeth Therapeutics Director Karen H. Vousden Granted 25,000 Stock Options - Kalkine Media

Faeth Therapeutics (FTH) awards 25,000 stock options to director - Stock Titan

Faeth Therapeutics at Cantor Fitzgerald conference: oral PI3K push By Investing.com - Investing.com Canada

A booming business on Wall Street would love more biotechs to quietly die - BioPharma Dive

TD Cowen initiates Faeth Therapeutics stock with buy rating By Investing.com - Investing.com South Africa

FTH Initiated Coverage by TD Cowen -- Rating Set to Buy - GuruFocus

TD Cowen initiates Faeth Therapeutics stock with buy rating By Investing.com - Investing.com India

TD Cowen initiates Faeth Therapeutics stock with buy rating By Investing.com - Investing.com Canada

TD Cowen initiates Faeth Therapeutics stock with buy rating By Investing.com - Investing.com UK

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - BioSpace

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - Yahoo Finance

About 80% of endometrial tumors have a pathway alteration. Faeth will discuss PIKTOR. - Stock Titan

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - Business Wire

Faeth Therapeutics stock hits 52-week high at 40.89 USD By Investing.com - Investing.com Australia

Faeth Therapeutics stock hits 52-week high at 40.89 USD - investing.com

Faeth Therapeutics stock hits 52-week high at 40.89 USD By Investing.com - Investing.com Canada

Bullish Faeth Therapeutics Insiders Rewarded As Their Investment Rises To US$1.94m - simplywall.st

Insiders of Faeth Therapeutics Getting Good Value On Their US$1.19m Investment - Moomoo

Biotech Stocks At 52-Week HighsOABI +13%, FRNM, EXEL, FTH, LFST - RTTNews

What Makes Faeth Therapeutics, Inc. (FTH) a Strong Momentum Stock: Buy Now? - Eastern Progress

Faeth Therapeutics to Participate in Upcoming September Investor Conferences - Business Wire

Faeth Therapeutics to Participate in Upcoming September Investor Conferences - Yahoo Finance Singapore

What Makes Faeth Therapeutics, Inc. (FTH) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Faeth Therapeutics (FTH) Grants Stock Options to New Hires Amid Unprofitable Growth Phase - GuruFocus

Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Capital expenditures of Faeth Therapeutics, Inc. – NASDAQ:FTH - TradingView

Wall Street Analysts Predict a 72.22% Upside in Faeth Therapeutics, Inc. (FTH): Here's What You Should Know - Yahoo Finance

FAETH THERAPEUTICS, INC : NEEDHAM INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $56 - Bitget

Needham initiates Faeth Therapeutics stock with buy rating on cancer drug potential - Investing.com Canada

FTH Initiates Coverage On by Needham -- Buy Rating with $56 Pric - GuruFocus

This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - sahmcapital.com

Khosla Ventures Seed Associates D, Llc Net Worth (2026) - GuruFocus

Why is Faeth Therapeutics stock surging today? By Investing.com - Investing.com Canada

Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - BioSpace

FDA grants fast track status to Faeth’s endometrial cancer drug - Investing.com

Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Ca - GuruFocus

FDA grants fast track status to Faeth’s endometrial cancer drug By Investing.com - Investing.com Canada

Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - Yahoo Finance

Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - Business Wire

FTH: Faeth Therapeutics, Inc.Insider Transations - Zacks Investment Research

Faeth Therapeutics (FTH) investor Caligan reports 2.4% stake in 13G/A - Stock Titan

Faeth Therapeutics (FTH) investor Trails Edge reports 2.0% beneficial stake in 13G/A - Stock Titan

Faeth Therapeutics (FTH): Khosla Ventures group discloses 10.2% ownership stake - Stock Titan

Faeth Therapeutics, Inc. (NASDAQ: FTH) Share Price, FTH Stock News, FTH Share Price & Updates - kalkine.ca

PR News | On the Move: Finn Names Flach PartnerFri., Aug. 14, 2026 - O'Dwyer's PR

Faeth Therapeutics (FTH) investor group reports 0% ownership in amended 13G - Stock Titan

Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments - TradingView

Faeth Therapeutics Adds Senior Leaders Ahead of PIKTOR Clinical Milestones - citybiz

Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments - BioSpace

GYRE

$5.85

0.85%

CRMD

$8.095

3.92%

CADL

$8.375

0.06%

FDMT

$11.86

6.06%

DNA

$9.73

2.80%

DSGN

$10.49

2.24%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters